Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Payables (2016 - 2025)

Merit Medical Systems' Payables history spans 16 years, with the latest figure at $60.6 million for Q4 2025.

  • For Q4 2025, Payables fell 11.61% year-over-year to $60.6 million; the TTM value through Dec 2025 reached $60.6 million, down 11.61%, while the annual FY2025 figure was $60.6 million, 11.61% down from the prior year.
  • Payables for Q4 2025 was $60.6 million at Merit Medical Systems, down from $64.7 million in the prior quarter.
  • Across five years, Payables topped out at $69.1 million in Q2 2025 and bottomed at $48.4 million in Q1 2024.
  • The 5-year median for Payables is $60.7 million (2024), against an average of $59.8 million.
  • The largest annual shift saw Payables decreased 26.24% in 2024 before it soared 31.8% in 2025.
  • A 5-year view of Payables shows it stood at $55.6 million in 2021, then grew by 23.16% to $68.5 million in 2022, then dropped by 3.74% to $65.9 million in 2023, then rose by 3.88% to $68.5 million in 2024, then dropped by 11.61% to $60.6 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Payables are $60.6 million (Q4 2025), $64.7 million (Q3 2025), and $69.1 million (Q2 2025).